Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushings syndrome and the vanishing effect of octreotide therapy


BARLAS T., KAYHAN G., YALÇIN M. M., CERİT E. T., AKTÜRK M. Y., TÖRÜNER F. S., ...More

The Endocrine Society, vol.2, 2024 (Peer-Reviewed Journal)